Drug
HEC53856 clinical trials
Also written HEC53856.
Keep track of what changes. Save the HEC53856 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- HEC53856
- 3
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses HEC53856 is read from its arms, and is right about nine times in ten.
Testing it · 4
- HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesNot yet recruitingPhase 2Sunshine Lake Pharma Co., Ltd.NCT07891377Written as HEC53856 tablet
- Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.CompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04925674Written as HEC53856
- HEC53856 Phase Ib Study in Patients With Non-dialysis Renal AnemiaCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04925661Written as HEC53856
- HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy VolunteersCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT03886688Written as HEC53856